Proton pump inhibitors and the risk of pancreatic cancer

J Gastroenterol. 2021 Mar;56(3):293-294. doi: 10.1007/s00535-021-01764-5. Epub 2021 Feb 5.

Author

Shih-Wei Lai^{1

2}

Affiliations

¹ Department of Public Health, College of Public Health and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan. wei@mail.cmuh.org.tw.
² Department of Family Medicine, China Medical University Hospital, No 2, Yu-De Road, Taichung city, Taiwan. wei@mail.cmuh.org.tw.

PMID: 33544263
DOI: 10.1007/s00535-021-01764-5

No abstract available

Publication types

Letter

MeSH terms

Cohort Studies
Humans
Pancreatic Neoplasms / epidemiology
Pancreatic Neoplasms / etiology*
Proton Pump Inhibitors / adverse effects*
Proton Pump Inhibitors / therapeutic use
Sweden

Substances

Proton Pump Inhibitors